Ich stimme der Verwendung von Cookies zu. Auch wenn ich diese Website weiter nutze, gilt dies als Zustimmung.

Bitte lesen und akzeptieren Sie die Datenschutzinformation und Cookie-Informationen, damit Sie unser Angebot weiter nutzen können. Natürlich können Sie diese Einwilligung jederzeit widerrufen.







APA-OTS-Meldungen aus dem Finanzsektor in der "BSN Extended Version"
Wichtige Originaltextaussendungen aus der Branche. Wir ergänzen vollautomatisch Bilder aus dem Fundus von photaq.com und Aktieninformationen aus dem Börse Social Network. Wer eine Korrektur zu den Beiträgen wünscht: mailto:office@boerse-social.com . Wir wiederum übernehmen keinerlei Haftung für Augenerkrankungen aufgrund von geballtem Grossbuchstabeneinsatz der Aussender. Wir meinen: Firmennamen, die länger als drei Buchstaben sind, schreibt man nicht durchgängig in Grossbuchstaben (Versalien).
Magazine aktuell


#gabb aktuell



14.08.2020, 14160 Zeichen

Corporate news transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is responsible for the content of this announcement.Mid Year ResultsVienna/Austria, 14 August 2020 -Slight decline in total revenue of 4.2% to EUR...

...418.9 million\nRevenue increase in the Medical Sector (+14.8%) almost compensated for the decline in the Industrial Sector (-13.9%) in absolute figures\nEBITDA increased by 47.2% to EUR 57.6 million, EBITDA margin from 9.0% to 13.7%\nEBIT improved many times over to EUR 112.2 million due to impairment reversal in the Sempermed segment amounting to EUR 88.8 million, EBIT margin from 4.8% to 26.8%\nAdjusted EBIT more than doubled to EUR 43.4 million\nDespite the disruptive external market shock of the corona pandemic and thesubsequent acceleration of the global economic recession, the publicly listedSemperit Group increased profitability in the first half of the year at bothEBITDA and EBIT level, thus improving the Group's liquidity at the same time:"We are looking back on a very positive earnings development in the first halfof the year," says Martin Füllenbach, Chairman of the Executive Board ofSemperit AG Holding. "Our comprehensive restructuring and transformationprogramme is now also bearing fruit in the Medical Sector: the operatingperformance was significantly improved. In addition, the exceptional boom inmedical protective gloves triggered by the corona pandemic and accompanied byprice increases has been a major factor. But the Industrial Sector, which issensitive to economic conditions, has also shown remarkable resilience to date."Successful crisis managementIn view of CoViD-19, the protection of the health of employees, customers andall stakeholders of the Semperit Group remains the top priority. Comprehensivemeasures were taken for the employees working in our production facilities.Since the second half of May, Semperit has implemented a gradual resumption ofoffice operations - in two separate teams. By the end of the first half of 2020,only 3 of around 7,000 employees worldwide had fallen ill with the corona virus,with none of the cases showing a serious course. "At a very early stage, wequickly introduced measures to protect the health of our employees on the onehand and to deal with the economic effects of the corona crisis in the bestpossible way on the other hand," says Füllenbach, satisfied with Semperit'scrisis management.Persistent external market shockThe Semperit Group achieved a significant increase in profitability andliquidity in the historically unprecedented crisis environment of the first halfof 2020. The recessionary developments observed since the second half of 2019were overlapped by an increasingly severe global economic depression in the wakeof the corona pandemic. The relevant raw material markets were largely indecline, primarily due to lower industrial demand and the collapse of crude oilprices in spring 2020. Even though a brief recovery of economic activities andsupply chains began in June-July 2020 after the easing of the global productionfreeze and the closure of public life, there were repeated setbacks and, in somecases, new closures in regional clusters. These market-relevant external factorswill increasingly impact the Semperit Group's business, particularly in theIndustrial Sector, in the second half of 2020, with recent developments ininfection figures pointing to the persistent danger of a renewed strongintensification or further corona waves in the coming months.Opposite effects of the corona pandemic on revenue developmentThe results of the Industrial Sector have been reported in the new structuresince 1 January 2020. The sector now consists of four segments (Semperflex,Sempertrans, Semperseal and Semperform), after Semperform was split into twoseparate segments: Semperseal deals with sealing profiles and elastomer sheets;Semperform combines the business units handrails, cable car rings, ski foils andengineered solutions (SES).The Semperit Group recorded a decrease in revenues of -4.2% to EUR 418.9 millionin the first half of 2020 compared to the same period of the previous year. Thecorona pandemic had opposite effects on the Medical and Industrial Sectors.Revenues in the Industrial Sector fell by -13.9%, while the Medical Sectorrecorded an increase of +14.8%.The Industrial Sector - above all the Semperflex segment - was affected on theone hand by the economic downturn, which began as early as 2019, and on theother by the negative effects of the Corona crisis. The increase in revenue inthe Medical Sector (Sempermed segment), is based on two factors: on the onehand, the increase in production volumes, which was made possible in part byimproved capacity utilisation, and on the other hand, the exceptionally highdemand for gloves as a result of the corona pandemic and the resulting increasein market prices.Continued strong increase in profitability combined with higher liquidityEBITDA rose from EUR 39.1 million in the first half of 2019 to EUR 57.6 millionin the first half of 2020 due to good results in the Medical Sector. In additionto the increases in sales volumes and market prices, the restructuring andtransformation measures, now also successful at Sempermed, had a positiveeffect. The EBITDA margin rose accordingly from 9.0% to 13.7%.In the context of the corona pandemic and the global economic slowdown, it wasnecessary to examine the segments of the Semperit Group for indications of achange in the value of segment assets. In the Sempermed and Sempertranssegments, this examination resulted in the need of an impairment reversal (ofEUR 88.8 million) and an impairment loss (of EUR 20.0 million) respectively.Accordingly, EBIT jumped to EUR 112.2 million in the first half of 2020 comparedto EUR 20.9 million in the first half of 2019, while the EBIT margin increasedfrom 4.8% to 26.8%. At EUR 43.4 million, EBIT adjusted for impairment losses wasnevertheless more than twice as high as in the first half of 2019, while theadjusted EBIT margin was 10.4% - also more than twice as high as in the sameperiod of the previous year.At EUR 11.9 million, cash-relevant investments in tangible and intangible assetsin the first half of 2020 were below the previous year's level of EUR 21.4million. The focus was mainly on capacity-maintaining investments. As of 30 June2020, cash and cash equivalents amounted to EUR 166.8 million, which was abovethe level of EUR 141.4 million at the end of 2019. This was, among other things,due to a higher operating result, and the reduction of investments in tangibleand intangible assets.Economic downturn and corona reduce results in the Industrial SectorThe Industrial Sector was hit by both the economic downturn that has beenapparent since 2019 and the effects of corona. The fact that the IndustrialSector is in a solid position thanks to the measures from the restructuring andtransformation programme had a supportive effect in this context. Strict costmanagement and close customer contact made it possible to partially offset thenegative effects of the crisis. In total, revenue in the sector fell by -13.9%from EUR 289.5 million to EUR 249.2 million.Thanks to the countermeasures taken in time during the corona crisis,profitability was only slightly below the previous year's level. Although EBITDAdeclined by -14,9% to EUR 44.8 million due to the decline in revenues, theEBITDA margin remained almost unchanged at 18.0% in the first half of 2020(after 18.2% in the first half of 2019). Due to current market developments, animpairment loss of EUR 20.0 million had to be recognised in the Sempertranssegment. EBIT thus declined by -69.1% to EUR 12.2 million and the EBIT marginfrom 13.6% to 4.9%. The adjusted EBIT was EUR 32.2 million and the EBIT marginwas 12.9%.Medical Sector on the rise after restructuring and positive corona effectsThe development of the Sempermed segment in the first half of 2020 wascharacterised by two main factors. On the one hand, production volumes andoperating efficiency were increased as a result of the successful restructuringmeasures. On the other hand, the significant increase in demand for medicalprotective gloves resulting from the corona pandemic - particularly in thesecond quarter - coupled with a market-driven rise in price levels was the mainreason for the positive result.Volumes rose significantly, contributing to the 14.8% year-on-year increase inrevenue. Due to the changed market situation, a reversal of an impairment lossof EUR 88.8 million was also recognised in the Sempermed segment.In addition to the sales boost due to corona, the measures of the restructuringand transformation process had a positive impact on the medical business notonly in terms of production volume and revenue growth, but also in terms ofproductivity and profitability: EBITDA was EUR 23.0 million in the first half of2020 after EUR -0.3 million in the first half of 2019. EBIT amounted to EUR110.7 million after EUR -4.2 million in the first half of 2019. EBIT adjustedfor the impairment reversal also improved significantly to EUR 21.9 million, theadjusted EBIT margin was above the level of the previous year at 12.9% (firsthalf of 2019:-2,9%).Executive Board mandate of Dr Felix Fremerey expires as plannedThe Executive Board mandate of Dr Felix Fremerey is scheduled to expire on 30November 2020. Dr Fremerey has informed the Supervisory Board that he is notavailable for an extension. Since Dr Fremerey joined the Executive Board inSeptember 2018 and under his leadership, the performance of the medical sectorhas improved significantly in all areas. This has laid the foundation for thisyear's outstanding earnings performance of the medical business. The operationalrestructuring has thus largely been successfully completed and a competentmanagement team has been established for the division. Dr Felix Fremerey istherefore resigning from his position on the Executive Board of Semperit AGHolding as of today in order to devote himself to new professional challenges.The Supervisory Board and colleagues on the Executive Board thank Felix Fremereyfor his outstanding performance, the extremely focused and pleasant personalcooperation and wish him all the best for his future career. CEO MartinFüllenbach (Business Medical Sector), COO Kristian Brok (Production OperationsMedical Sector) and CFO Petra Preining (IT) will assume his responsibilities atSemperit.OutlookThe recessive economic development and the effects of the corona crisis lead toopposing developments in the Industrial and Medical Sectors: In the medicalprotective gloves business, a significant increase in demand and a sharp rise inprices have been observed since the outbreak of the corona crisis. Against thisbackground and also in view of the improved operational performance, the resultsof the Medical Sector in the current financial year will be significantly abovethe previous year's level.The emerging effects of the global pandemic are considered to be of limitedsustainability. For this reason, the fundamental strategic decision of 28January 2020, according to which Semperit will focus on the industrial rubberbusiness in the future and separate from the medical business, is still valid,regardless of the developments recently observed in the wake of the coronacrisis. The implementation of the separation from the medical business will bedelayed.The Industrial Sector was hit by the global recession, which has worsened inrecent months due to the global lockdown. The results of the Industrial Sectorin the current year will therefore be noticeably below the previous year'slevel. The positive effects from the medical business for the foreseeable futurewill, however, more than compensate for this decline.Overall, based on the current figures, EBITDA of the Semperit Group is currentlyexpected to be significantly higher than in the previous year (2019: EUR 67.8million) for the full year. However, the currently unpredictable duration of thecorona crisis and its consequences for the global economy make it difficult toreliably forecast the financial effects on the Semperit Group.In view of the developments described above, indications were examined and areversal of an impairment loss in the Sempermed segment and an impairment in theSempertrans segment were determined at the end of the second quarter of 2020.Taking this into account, EBIT of the Semperit Group of EUR 110 to 160 million(2019: EUR -16.5 million) is expected for 2020 as a whole - particularlydepending on the further development of the price level for medical protectivegloves and the sufficient availability of raw materials for their production.These expectations were already communicated in the ad-hoc mailing of theSemperit Group on 3 July 2020.Against this background, Semperit expects the second half of the year to becharacterised by significant challenges. This will be reflected in visibly lowerresults in the Industrial Sector: the corona crisis and the resultingintensified economic downturn are expected to have a slightly delayed effect onthe Semperit Group. However, significant declines in revenues and earnings areexpected particularly from the second half of the year. In contrast, the resultin the Medical Sector will be positively influenced by the significantly higherdemand and price increases in the market.The restructuring and transformation process initiated by the Semperit Group atthe beginning of 2018, which has led to significant improvements at variouslevels, has been further accelerated by the corona crisis and will continue inthe future: In this context, the focus on cost-cutting measures will besharpened again in the coming months.end of announcement euro adhocissuer: Semperit AG Holding Modecenterstrasse 22 A-1030 Wienphone: +43 1 79 777-310FAX: +43 1 79 777-602mail: judit.helenyi@semperitgroup.comWWW: www.semperitgroup.comISIN: AT0000785555indexes: ATX GP, WBI, ATX PRIMEstockmarkets: Wienlanguage: EnglishDigital press kit: http://www.ots.at/pressemappe/2918/aom

Börse Social Network Subscription

Um diesen Artikel zu lesen, müssen Sie eine Mitgliedschaft erwerben.

Tagespass 8.00 Euro /einmalig

15.00 Euro /monatlich



BSN Podcasts
Christian Drastil: Wiener Börse Plausch

Austrian Stocks in English: In Week 39 we saw Longtime Lows, a Qualifying and Elvis Costello




Semperit
Akt. Indikation:  16.90 / 16.98
Uhrzeit:  19:00:18
Veränderung zu letztem SK:  -1.51%
Letzter SK:  17.20 ( 0.00%)



 

Bildnachweis

1. Semperit Group, Werk in Wimpassing, Credit: Semperit , (© Aussender)   >> Öffnen auf photaq.com

Aktien auf dem Radar:Flughafen Wien, Lenzing, CA Immo, Warimpex, Addiko Bank, Rosenbauer, Kapsch TrafficCom, Pierer Mobility, UBM, AMS, Athos Immobilien, AT&S, Bawag, Cleen Energy, Frauenthal, Polytec Group, Rath AG, Wienerberger, Wiener Privatbank, Oberbank AG Stamm, Zumtobel, Telekom Austria, Immofinanz, S Immo, Strabag, Deutsche Boerse, Merck KGaA, Münchener Rück, Fresenius Medical Care, Siemens Healthineers, Bayer.


Random Partner

A1 Telekom Austria
Die an der Wiener Börse notierte A1 Telekom Austria Group ist führender Provider für digitale Services und Kommunikationslösungen im CEE Raum mit mehr als 24 Millionen Kunden in sieben Ländern und bietet Kommunikationslösungen, Payment und Unterhaltungsservices sowie integrierte Business Lösungen an.

>> Besuchen Sie 64 weitere Partner auf boerse-social.com/partner


Mehr aktuelle OTS-Meldungen HIER

Useletter

Die Useletter "Morning Xpresso" und "Evening Xtrakt" heben sich deutlich von den gängigen Newslettern ab. Beispiele ansehen bzw. kostenfrei anmelden. Wichtige Börse-Infos garantiert.

Newsletter abonnieren

Runplugged

Infos über neue Financial Literacy Audio Files für die Runplugged App
(kostenfrei downloaden über http://runplugged.com/spreadit)

per Newsletter erhalten


Meistgelesen
>> mehr





PIR-Zeichnungsprodukte
AT0000A2TRJ1
AT0000A2XLE7
AT0000A2T4E5


Newsflow
>> mehr

Börse Social Club Board
>> mehr
    #gabb #1192

    Featured Partner Video

    Wiener Börse Plausch S3/13: Holger Zschäpitz mein Backup, Superhelden-Name Wolfgang Matejka, Angst vor der Gewinn-Messe

    Die Wiener Börse Pläusche sind ein Podcastprojekt von Christian Drastil Comm. Unter dem Motto „Market & Me“ berichtet Christian Drastil über das Tagesgeschehen an der...

    Books josefchladek.com

    Garry Winogrand
    Women are beautiful
    1975
    Light Gallery Books

    Michel Mazzoni
    Rien, presque
    2022
    MER. B&L

    Stephan Keppel
    Immer Zimmer
    2022
    Fw: Books

    Kishin Shinoyama
    A Fine Day (篠山 紀信
    1977
    Heibon-Sha

    Lars Tunbjörk
    Vinter
    2007
    Steidl

    Semperit with profitability boost in the first half of the year: efficiency enhancement, strict corona countermeasures and high market demand in the Medical Sector take effect


    14.08.2020, 14160 Zeichen

    Corporate news transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is responsible for the content of this announcement.Mid Year ResultsVienna/Austria, 14 August 2020 -Slight decline in total revenue of 4.2% to EUR...

    ...418.9 million\nRevenue increase in the Medical Sector (+14.8%) almost compensated for the decline in the Industrial Sector (-13.9%) in absolute figures\nEBITDA increased by 47.2% to EUR 57.6 million, EBITDA margin from 9.0% to 13.7%\nEBIT improved many times over to EUR 112.2 million due to impairment reversal in the Sempermed segment amounting to EUR 88.8 million, EBIT margin from 4.8% to 26.8%\nAdjusted EBIT more than doubled to EUR 43.4 million\nDespite the disruptive external market shock of the corona pandemic and thesubsequent acceleration of the global economic recession, the publicly listedSemperit Group increased profitability in the first half of the year at bothEBITDA and EBIT level, thus improving the Group's liquidity at the same time:"We are looking back on a very positive earnings development in the first halfof the year," says Martin Füllenbach, Chairman of the Executive Board ofSemperit AG Holding. "Our comprehensive restructuring and transformationprogramme is now also bearing fruit in the Medical Sector: the operatingperformance was significantly improved. In addition, the exceptional boom inmedical protective gloves triggered by the corona pandemic and accompanied byprice increases has been a major factor. But the Industrial Sector, which issensitive to economic conditions, has also shown remarkable resilience to date."Successful crisis managementIn view of CoViD-19, the protection of the health of employees, customers andall stakeholders of the Semperit Group remains the top priority. Comprehensivemeasures were taken for the employees working in our production facilities.Since the second half of May, Semperit has implemented a gradual resumption ofoffice operations - in two separate teams. By the end of the first half of 2020,only 3 of around 7,000 employees worldwide had fallen ill with the corona virus,with none of the cases showing a serious course. "At a very early stage, wequickly introduced measures to protect the health of our employees on the onehand and to deal with the economic effects of the corona crisis in the bestpossible way on the other hand," says Füllenbach, satisfied with Semperit'scrisis management.Persistent external market shockThe Semperit Group achieved a significant increase in profitability andliquidity in the historically unprecedented crisis environment of the first halfof 2020. The recessionary developments observed since the second half of 2019were overlapped by an increasingly severe global economic depression in the wakeof the corona pandemic. The relevant raw material markets were largely indecline, primarily due to lower industrial demand and the collapse of crude oilprices in spring 2020. Even though a brief recovery of economic activities andsupply chains began in June-July 2020 after the easing of the global productionfreeze and the closure of public life, there were repeated setbacks and, in somecases, new closures in regional clusters. These market-relevant external factorswill increasingly impact the Semperit Group's business, particularly in theIndustrial Sector, in the second half of 2020, with recent developments ininfection figures pointing to the persistent danger of a renewed strongintensification or further corona waves in the coming months.Opposite effects of the corona pandemic on revenue developmentThe results of the Industrial Sector have been reported in the new structuresince 1 January 2020. The sector now consists of four segments (Semperflex,Sempertrans, Semperseal and Semperform), after Semperform was split into twoseparate segments: Semperseal deals with sealing profiles and elastomer sheets;Semperform combines the business units handrails, cable car rings, ski foils andengineered solutions (SES).The Semperit Group recorded a decrease in revenues of -4.2% to EUR 418.9 millionin the first half of 2020 compared to the same period of the previous year. Thecorona pandemic had opposite effects on the Medical and Industrial Sectors.Revenues in the Industrial Sector fell by -13.9%, while the Medical Sectorrecorded an increase of +14.8%.The Industrial Sector - above all the Semperflex segment - was affected on theone hand by the economic downturn, which began as early as 2019, and on theother by the negative effects of the Corona crisis. The increase in revenue inthe Medical Sector (Sempermed segment), is based on two factors: on the onehand, the increase in production volumes, which was made possible in part byimproved capacity utilisation, and on the other hand, the exceptionally highdemand for gloves as a result of the corona pandemic and the resulting increasein market prices.Continued strong increase in profitability combined with higher liquidityEBITDA rose from EUR 39.1 million in the first half of 2019 to EUR 57.6 millionin the first half of 2020 due to good results in the Medical Sector. In additionto the increases in sales volumes and market prices, the restructuring andtransformation measures, now also successful at Sempermed, had a positiveeffect. The EBITDA margin rose accordingly from 9.0% to 13.7%.In the context of the corona pandemic and the global economic slowdown, it wasnecessary to examine the segments of the Semperit Group for indications of achange in the value of segment assets. In the Sempermed and Sempertranssegments, this examination resulted in the need of an impairment reversal (ofEUR 88.8 million) and an impairment loss (of EUR 20.0 million) respectively.Accordingly, EBIT jumped to EUR 112.2 million in the first half of 2020 comparedto EUR 20.9 million in the first half of 2019, while the EBIT margin increasedfrom 4.8% to 26.8%. At EUR 43.4 million, EBIT adjusted for impairment losses wasnevertheless more than twice as high as in the first half of 2019, while theadjusted EBIT margin was 10.4% - also more than twice as high as in the sameperiod of the previous year.At EUR 11.9 million, cash-relevant investments in tangible and intangible assetsin the first half of 2020 were below the previous year's level of EUR 21.4million. The focus was mainly on capacity-maintaining investments. As of 30 June2020, cash and cash equivalents amounted to EUR 166.8 million, which was abovethe level of EUR 141.4 million at the end of 2019. This was, among other things,due to a higher operating result, and the reduction of investments in tangibleand intangible assets.Economic downturn and corona reduce results in the Industrial SectorThe Industrial Sector was hit by both the economic downturn that has beenapparent since 2019 and the effects of corona. The fact that the IndustrialSector is in a solid position thanks to the measures from the restructuring andtransformation programme had a supportive effect in this context. Strict costmanagement and close customer contact made it possible to partially offset thenegative effects of the crisis. In total, revenue in the sector fell by -13.9%from EUR 289.5 million to EUR 249.2 million.Thanks to the countermeasures taken in time during the corona crisis,profitability was only slightly below the previous year's level. Although EBITDAdeclined by -14,9% to EUR 44.8 million due to the decline in revenues, theEBITDA margin remained almost unchanged at 18.0% in the first half of 2020(after 18.2% in the first half of 2019). Due to current market developments, animpairment loss of EUR 20.0 million had to be recognised in the Sempertranssegment. EBIT thus declined by -69.1% to EUR 12.2 million and the EBIT marginfrom 13.6% to 4.9%. The adjusted EBIT was EUR 32.2 million and the EBIT marginwas 12.9%.Medical Sector on the rise after restructuring and positive corona effectsThe development of the Sempermed segment in the first half of 2020 wascharacterised by two main factors. On the one hand, production volumes andoperating efficiency were increased as a result of the successful restructuringmeasures. On the other hand, the significant increase in demand for medicalprotective gloves resulting from the corona pandemic - particularly in thesecond quarter - coupled with a market-driven rise in price levels was the mainreason for the positive result.Volumes rose significantly, contributing to the 14.8% year-on-year increase inrevenue. Due to the changed market situation, a reversal of an impairment lossof EUR 88.8 million was also recognised in the Sempermed segment.In addition to the sales boost due to corona, the measures of the restructuringand transformation process had a positive impact on the medical business notonly in terms of production volume and revenue growth, but also in terms ofproductivity and profitability: EBITDA was EUR 23.0 million in the first half of2020 after EUR -0.3 million in the first half of 2019. EBIT amounted to EUR110.7 million after EUR -4.2 million in the first half of 2019. EBIT adjustedfor the impairment reversal also improved significantly to EUR 21.9 million, theadjusted EBIT margin was above the level of the previous year at 12.9% (firsthalf of 2019:-2,9%).Executive Board mandate of Dr Felix Fremerey expires as plannedThe Executive Board mandate of Dr Felix Fremerey is scheduled to expire on 30November 2020. Dr Fremerey has informed the Supervisory Board that he is notavailable for an extension. Since Dr Fremerey joined the Executive Board inSeptember 2018 and under his leadership, the performance of the medical sectorhas improved significantly in all areas. This has laid the foundation for thisyear's outstanding earnings performance of the medical business. The operationalrestructuring has thus largely been successfully completed and a competentmanagement team has been established for the division. Dr Felix Fremerey istherefore resigning from his position on the Executive Board of Semperit AGHolding as of today in order to devote himself to new professional challenges.The Supervisory Board and colleagues on the Executive Board thank Felix Fremereyfor his outstanding performance, the extremely focused and pleasant personalcooperation and wish him all the best for his future career. CEO MartinFüllenbach (Business Medical Sector), COO Kristian Brok (Production OperationsMedical Sector) and CFO Petra Preining (IT) will assume his responsibilities atSemperit.OutlookThe recessive economic development and the effects of the corona crisis lead toopposing developments in the Industrial and Medical Sectors: In the medicalprotective gloves business, a significant increase in demand and a sharp rise inprices have been observed since the outbreak of the corona crisis. Against thisbackground and also in view of the improved operational performance, the resultsof the Medical Sector in the current financial year will be significantly abovethe previous year's level.The emerging effects of the global pandemic are considered to be of limitedsustainability. For this reason, the fundamental strategic decision of 28January 2020, according to which Semperit will focus on the industrial rubberbusiness in the future and separate from the medical business, is still valid,regardless of the developments recently observed in the wake of the coronacrisis. The implementation of the separation from the medical business will bedelayed.The Industrial Sector was hit by the global recession, which has worsened inrecent months due to the global lockdown. The results of the Industrial Sectorin the current year will therefore be noticeably below the previous year'slevel. The positive effects from the medical business for the foreseeable futurewill, however, more than compensate for this decline.Overall, based on the current figures, EBITDA of the Semperit Group is currentlyexpected to be significantly higher than in the previous year (2019: EUR 67.8million) for the full year. However, the currently unpredictable duration of thecorona crisis and its consequences for the global economy make it difficult toreliably forecast the financial effects on the Semperit Group.In view of the developments described above, indications were examined and areversal of an impairment loss in the Sempermed segment and an impairment in theSempertrans segment were determined at the end of the second quarter of 2020.Taking this into account, EBIT of the Semperit Group of EUR 110 to 160 million(2019: EUR -16.5 million) is expected for 2020 as a whole - particularlydepending on the further development of the price level for medical protectivegloves and the sufficient availability of raw materials for their production.These expectations were already communicated in the ad-hoc mailing of theSemperit Group on 3 July 2020.Against this background, Semperit expects the second half of the year to becharacterised by significant challenges. This will be reflected in visibly lowerresults in the Industrial Sector: the corona crisis and the resultingintensified economic downturn are expected to have a slightly delayed effect onthe Semperit Group. However, significant declines in revenues and earnings areexpected particularly from the second half of the year. In contrast, the resultin the Medical Sector will be positively influenced by the significantly higherdemand and price increases in the market.The restructuring and transformation process initiated by the Semperit Group atthe beginning of 2018, which has led to significant improvements at variouslevels, has been further accelerated by the corona crisis and will continue inthe future: In this context, the focus on cost-cutting measures will besharpened again in the coming months.end of announcement euro adhocissuer: Semperit AG Holding Modecenterstrasse 22 A-1030 Wienphone: +43 1 79 777-310FAX: +43 1 79 777-602mail: judit.helenyi@semperitgroup.comWWW: www.semperitgroup.comISIN: AT0000785555indexes: ATX GP, WBI, ATX PRIMEstockmarkets: Wienlanguage: EnglishDigital press kit: http://www.ots.at/pressemappe/2918/aom

    Börse Social Network Subscription

    Um diesen Artikel zu lesen, müssen Sie eine Mitgliedschaft erwerben.

    Tagespass 8.00 Euro /einmalig

    15.00 Euro /monatlich



    BSN Podcasts
    Christian Drastil: Wiener Börse Plausch

    Austrian Stocks in English: In Week 39 we saw Longtime Lows, a Qualifying and Elvis Costello




    Semperit
    Akt. Indikation:  16.90 / 16.98
    Uhrzeit:  19:00:18
    Veränderung zu letztem SK:  -1.51%
    Letzter SK:  17.20 ( 0.00%)



     

    Bildnachweis

    1. Semperit Group, Werk in Wimpassing, Credit: Semperit , (© Aussender)   >> Öffnen auf photaq.com

    Aktien auf dem Radar:Flughafen Wien, Lenzing, CA Immo, Warimpex, Addiko Bank, Rosenbauer, Kapsch TrafficCom, Pierer Mobility, UBM, AMS, Athos Immobilien, AT&S, Bawag, Cleen Energy, Frauenthal, Polytec Group, Rath AG, Wienerberger, Wiener Privatbank, Oberbank AG Stamm, Zumtobel, Telekom Austria, Immofinanz, S Immo, Strabag, Deutsche Boerse, Merck KGaA, Münchener Rück, Fresenius Medical Care, Siemens Healthineers, Bayer.


    Random Partner

    A1 Telekom Austria
    Die an der Wiener Börse notierte A1 Telekom Austria Group ist führender Provider für digitale Services und Kommunikationslösungen im CEE Raum mit mehr als 24 Millionen Kunden in sieben Ländern und bietet Kommunikationslösungen, Payment und Unterhaltungsservices sowie integrierte Business Lösungen an.

    >> Besuchen Sie 64 weitere Partner auf boerse-social.com/partner


    Mehr aktuelle OTS-Meldungen HIER

    Useletter

    Die Useletter "Morning Xpresso" und "Evening Xtrakt" heben sich deutlich von den gängigen Newslettern ab. Beispiele ansehen bzw. kostenfrei anmelden. Wichtige Börse-Infos garantiert.

    Newsletter abonnieren

    Runplugged

    Infos über neue Financial Literacy Audio Files für die Runplugged App
    (kostenfrei downloaden über http://runplugged.com/spreadit)

    per Newsletter erhalten


    Meistgelesen
    >> mehr





    PIR-Zeichnungsprodukte
    AT0000A2TRJ1
    AT0000A2XLE7
    AT0000A2T4E5


    Newsflow
    >> mehr

    Börse Social Club Board
    >> mehr
      #gabb #1192

      Featured Partner Video

      Wiener Börse Plausch S3/13: Holger Zschäpitz mein Backup, Superhelden-Name Wolfgang Matejka, Angst vor der Gewinn-Messe

      Die Wiener Börse Pläusche sind ein Podcastprojekt von Christian Drastil Comm. Unter dem Motto „Market & Me“ berichtet Christian Drastil über das Tagesgeschehen an der...

      Books josefchladek.com

      Paul Fusco
      RFK Funeral Train
      2000
      Umbrage Editions

      Robert Frank
      Die Amerikaner (1st Swiss edition)
      1986
      Buchclub Ex Libris Zürich

      Lewis Baltz
      Park City
      1980
      Artspace Press and Castelli Graphics

      Martin Ogolter
      12 conversas e uma festa
      2021
      Self published

      Ben Sakamoto & Yoshinari Nishimura
      Sonotoki, Kaze ga, Yonin no mune wo kushizashi ni shita (坂本 勉 & 西村 佳也
      1981
      West Village